Key result
Sympathetic blockade linked to ~73% lower 1-week mortality vs ACLS antiarrhythmics in electrical storm.
Why the study?
Treating electrical storm according to ACLS guidelines yields poor outcomes, necessitating evaluation of sympathetic blockade efficacy.
Does sympathetic blockade reduce mortality compared to ACLS guidelines in patients with electrical storm associated with recent myocardial infarction?
Cohort (n=49)
Does sympathetic blockade reduce mortality compared to ACLS guidelines in patients with electrical storm associated with recent myocardial infarction?
Sympathetic blockade significantly improves short- and long-term survival compared to standard ACLS antiarrhythmic therapy in patients experiencing electrical storm after a recent myocardial infarction.
Answers are grounded in this paper and cite their sources.
Sympathetic blockade was associated with lower post-MI electrical storm mortality; leaves open whether it improves outcomes over ACLS in randomized trials.
BACKGROUND: Electrical storm (ES), defined as recurrent multiple ventricular fibrillation (VF) episodes, often occurs in patients with recent myocardial infarction. Because treating ES according to the Advanced Cardiac Life Support (ACLS) guidelines yields a poor outcome, we evaluated the efficacy of sympathetic blockade in treating ES patients and compared their outcome with that of patients treated according to the ACLS guidelines. METHODS AND RESULTS: Forty-nine patients (36 men, 13 women, mean age 57+/-10 years) who had ES associated with a recent myocardial infarction were separated into 2 groups. Patients in group 1 (n=27) received sympathetic blockade treatment: 6 left stellate ganglionic blockade, 7 esmolol, and 14 propranolol. Patients in group 2 (n=22) received antiarrhythmic medication as recommended by the ACLS guidelines. Patient characteristics were similar in the 2 groups. The 1-week mortality rate was higher in group 2: 18 (82%) of the 22 patients died, all of refractory VF; 6 (22%) of the 27 group 1 patients died, 3 of refractory VF (P<0.0001). Patients who survived the initial ES event did well over the 1-year follow-up period: Overall survival in group 1 was 67%, compared with 5% in group 2 (P<0.0001). CONCLUSIONS: Sympathetic blockade is superior to the antiarrhythmic therapy recommended by the ACLS guidelines in treating ES patients. Our study emphasizes the role of increased sympathetic activity in the genesis of ES. Sympathetic blockade-not class 1 antiarrhythmic drugs-should be the treatment of choice for ES.
No takes yet. Share an insight, caveat, or question.
Nademanee et al. (2000) conducted a cohort in Electrical storm (ES) associated with a recent myocardial infarction (n=49). Sympathetic blockade vs. Antiarrhythmic medication according to ACLS guidelines was evaluated on 1-week mortality rate (p=<0.0001). Sympathetic blockade was superior to ACLS-recommended antiarrhythmic therapy, reducing 1-week mortality in patients with electrical storm.
Synapse has enriched 10 related papers. Consider them for comparative context: